Add BrightSurf on Google Email

Science News for May 3, 2025


New model supercharges human-AI team work in high-stakes industries

A novel model predicts critical energy barriers governing heavy-ion fusion reactions with high accuracy, enabling the synthesis of superheavy nuclei and improving nuclear physics experiments. The model's effective nucleus-nucleus potential combines Skyrme energy density functional with reaction Q-values.

SourceNuclear Science and Techniques·JournalNuclear Science and Techniques·TypeComputational simulation/modeling·DateMay 3, 2025

SCAI announces Srihari S. Naidu, MD, MSCAI, President for 2025–26

SCAI has announced its new leadership for 2025–26, with Dr. Srihari S. Naidu assuming the role of President during SCAI Scientific Sessions 2025. Dr. Naidu plans to prioritize practical, high-impact science, advocating for policies that protect and empower the workforce.

SourceSociety for Cardiovascular Angiography and Interventions·DateMay 3, 2025
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

SCAI Announces Recipient of the 2025–26 SCAI Women in Innovations (WIN) Complex and High-Risk Coronary Intervention (CHIP) Fellowship

Dr. Samantha Espinosa has been selected for the WIN-CHIP Fellowship to advance her training in complex procedures and contribute to women's representation in interventional cardiology. The fellowship aims to provide comprehensive technical training while addressing systemic barriers.

SourceSociety for Cardiovascular Angiography and Interventions·DateMay 3, 2025

SCAI bestows highest designation ranking to leading interventional cardiologists

The Society for Cardiovascular Angiography & Interventions (SCAI) has recognized the expertise of its top interventionalists, who demonstrate excellence in clinical care, innovation, publication, and teaching. The MSCAI designation is awarded to outstanding individuals who have made significant contributions to the field.

SourceSociety for Cardiovascular Angiography and Interventions·DateMay 3, 2025

Ready to Launch Program to spotlight careers in interventional cardiology at SCAI Scientific Sessions 2025

The Society for Cardiovascular Angiography and Interventions (SCAI) has launched a program called Ready to Launch, which connects medical students and early-career residents with leaders in interventional cardiology. The program aims to provide exposure to real-world clinical scenarios and lasting professional relationships.

SourceSociety for Cardiovascular Angiography and Interventions·DateMay 3, 2025

SCAI’s 30 in Their 30s Award recognizes excellence among early-career interventional cardiologists at SCAI Scientific Sessions 2025

The Society for Cardiovascular Angiography & Interventions (SCAI) recognized 30 exceptional early-career interventionalists who demonstrate leadership, clinical excellence, and a commitment to teamwork and service. The award celebrates their embodiment of SCAI's core values and clear potential to shape the future of the profession.

SourceSociety for Cardiovascular Angiography and Interventions·DateMay 3, 2025

Five major advances in anal and rectal cancer treatment with radiotherapy

New studies showcase radiotherapy's potential as a curative treatment for rectal cancer, offering safer alternatives to surgery. Reduced-dose treatments and immunotherapy-combined regimens have improved tumour control and reduced side effects.

SourceEuropean Society for Radiotherapy and Oncology (ESTRO)·TypeRandomized controlled/clinical trial·DateMay 3, 2025
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Scientists fight Alzheimer’s by helping glial cells process glucose

Researchers have found that promoting glucose metabolism in glial cells can relieve inflammation and photoreceptor degeneration in Alzheimer's patients. This discovery presents an exciting new therapeutic target for treating neurodegenerative conditions like Parkinson's.

SourceTokyo Metropolitan University·JournalDisease Models & Mechanisms·DateMay 3, 2025